Literature DB >> 27864413

Cohort Profile: Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.

Geneviève Chêne1,2,3, Andrew Phillips4, Dominique Costagliola5, Jonathan A C Sterne6, Hansjakob Furrer7, Julia Del Amo8,9, Amanda Mocroft4, Antonella d'Arminio Monforte10, François Dabis1,2,3, José M Miro11, Diana Barger1,2, Monique Termote1,2, Christine Schwimmer1,2, Rikke Salbøl Brandt12, Nina Friis-Moller12,13, Dorthe Raben12, David Haerry14, Matthias Egger15,16, Ian Weller4, Stéphane De Wit17.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27864413      PMCID： PMC6236919          DOI： 10.1093/ije/dyw211

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN： 0300-5771            Impact factor:   7.196


× No keyword cloud information.
  25 in total

1.  HIV cohort collaborations: proposal for harmonization of data exchange.

Authors:  Jesper Kjaer; Bruno Ledergerber
Journal:  Antivir Ther       Date:  2004-08

2.  Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?

Authors:  Amanda Mocroft; Peter Reiss; Ole Kirk; Cristina Mussini; Enrico Girardi; Philippe Morlat; Christoph Stephan; Stephane De Wit; Katja Doerholt; Jade Ghosn; Heiner C Bucher; Jens D Lundgren; Genevieve Chene; Jose M Miro; Hansjakob Furrer
Journal:  Clin Infect Dis       Date:  2010-09-01       Impact factor: 9.079

3.  Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.

Authors:  David R Boulware; David B Meya; Conrad Muzoora; Melissa A Rolfes; Katherine Huppler Hullsiek; Abdu Musubire; Kabanda Taseera; Henry W Nabeta; Charlotte Schutz; Darlisha A Williams; Radha Rajasingham; Joshua Rhein; Friedrich Thienemann; Melanie W Lo; Kirsten Nielsen; Tracy L Bergemann; Andrew Kambugu; Yukari C Manabe; Edward N Janoff; Paul R Bohjanen; Graeme Meintjes
Journal:  N Engl J Med       Date:  2014-06-26       Impact factor: 91.245

4.  The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era.

Authors:  A Mocroft; H J Furrer; J M Miro; P Reiss; C Mussini; O Kirk; S Abgrall; S Ayayi; B Bartmeyer; D Braun; A Castagna; A d'Arminio Monforte; B Gazzard; F Gutierrez; I Hurtado; K Jansen; L Meyer; P Muñoz; N Obel; P Soler-Palacin; A Papadopoulos; F Raffi; J T Ramos; J K Rockstroh; D Salmon; C Torti; J Warszawski; S de Wit; R Zangerle; C Fabre-Colin; J Kjaer; G Chene; J Grarup; J D Lundgren
Journal:  Clin Infect Dis       Date:  2013-08-06       Impact factor: 9.079

5.  Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis.

Authors:  Gregory P Bisson; Mooketsi Molefi; Scarlett Bellamy; Rameshwari Thakur; Andrew Steenhoff; Neo Tamuhla; Tumelo Rantleru; Irene Tsimako; Stephen Gluckman; Shruthi Ravimohan; Drew Weissman; Pablo Tebas
Journal:  Clin Infect Dis       Date:  2013-01-29       Impact factor: 9.079

6.  Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe.

Authors:  Fumiyo Nakagawa; Rebecca Lodwick; Dominique Costagliola; Ard van Sighem; Carlo Torti; Daniel Podzamczer; Amanda Mocroft; Bruno Ledergerber; Maria Dorrucci; Alessandra Cozzi-Lepri; Klaus Jansen; Bernard Masquelier; Federico García; Stephane De Wit; Christoph Stephan; Niels Obel; Gerd Fätkenhaeuer; Antonella Castagna; Helen Sambatakou; Cristina Mussini; Jade Ghosn; Robert Zangerle; Xavier Duval; Laurence Meyer; Santiago Perez-Hoyos; Céline Fabre Colin; Jesper Kjaer; Genevieve Chene; Jesper Grarup; Andrew Phillips
Journal:  J Acquir Immune Defic Syndr       Date:  2012-03-01       Impact factor: 3.731

7.  Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years.

Authors:  Rebecca Lodwick; Dominique Costagliola; Peter Reiss; Carlo Torti; Ramón Teira; Maria Dorrucci; Bruno Ledergerber; Amanda Mocroft; Daniel Podzamczer; Alessandro Cozzi-Lepri; Niels Obel; Bernard Masquelier; Schlomo Staszewski; Federico García; Stephane De Wit; Antonella Castagna; Andrea Antinori; Ali Judd; Jade Ghosn; Giota Touloumi; Cristina Mussini; Xavier Duval; José Ramos; Laurence Meyer; Josiane Warsawski; Claire Thorne; Joan Masip; Santiago Pérez-Hoyos; Deenan Pillay; Ard van Sighem; Sergio Lo Caputo; Huldrych Günthard; Roger Paredes; Andrea De Luca; Dimitrios Paraskevis; Céline Fabre-Colin; Jesper Kjaer; Genèvieve Chêne; Jens D Lundgren; Andrew N Phillips
Journal:  Arch Intern Med       Date:  2010-03-08

8.  Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery.

Authors:  Frederik N Engsig; Robert Zangerle; Olga Katsarou; Francois Dabis; Peter Reiss; John Gill; Kholoud Porter; Caroline Sabin; Andrew Riordan; Gerd Fätkenheuer; Félix Gutiérrez; Francois Raffi; Ole Kirk; Murielle Mary-Krause; Christoph Stephan; Patricia Garcia de Olalla; Jodie Guest; Hasina Samji; Antonella Castagna; Antonella d'Arminio Monforte; Adriane Skaletz-Rorowski; Jose Ramos; Giuseppe Lapadula; Cristina Mussini; Lluís Force; Laurence Meyer; Fiona Lampe; Faroudy Boufassa; Heiner C Bucher; Stéphane De Wit; Greer A Burkholder; Ramon Teira; Amy C Justice; Tim R Sterling; Heidi M Crane; Jan Gerstoft; Jesper Grarup; Margaret May; Geneviève Chêne; Suzanne M Ingle; Jonathan Sterne; Niels Obel
Journal:  Clin Infect Dis       Date:  2014-01-22       Impact factor: 9.079

9.  Effect of hepatitis C treatment on CD4+ T-cell counts and the risk of death in HIV-HCV-coinfected patients: the COHERE collaboration.

Authors: 
Journal:  Antivir Ther       Date:  2012-07-24

10.  Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes.

Authors:  Dominique Costagliola; Bruno Ledergerber; Carlo Torti; Ard van Sighem; Daniel Podzamczer; Amanda Mocroft; Maria Dorrucci; Bernard Masquelier; Andrea de Luca; Klaus Jansen; Stephane De Wit; Niels Obel; Gerd Fätkenheuer; Giota Touloumi; Cristina Mussini; Antonella Castagna; Cristoph Stephan; Federico García; Robert Zangerle; Xavier Duval; Santiago Perez-Hoyos; Laurence Meyer; Jade Ghosn; Céline Fabre-Colin; Jesper Kjaer; Genevieve Chêne; Jesper Grarup; Andrew Phillips; Rebecca Lodwick; Carlo Torti; Maria Dorrucci; Huldrych F Günthard; Claudia Michalik; George Chrysos; Antonella Castagna
Journal:  J Infect Dis       Date:  2012-12-07       Impact factor: 5.226
View more
  11 in total

1.  Cervical cancer risk in women living with HIV across four continents: A multicohort study.

Authors:  Eliane Rohner; Lukas Bütikofer; Kurt Schmidlin; Mazvita Sengayi; Mhairi Maskew; Janet Giddy; Katayoun Taghavi; Richard D Moore; James J Goedert; M John Gill; Michael J Silverberg; Gypsyamber D'Souza; Pragna Patel; Jessica L Castilho; Jeremy Ross; Annette Sohn; Firouze Bani-Sadr; Ninon Taylor; Vassilios Paparizos; Fabrice Bonnet; Annelies Verbon; Jörg Janne Vehreschild; Frank A Post; Caroline Sabin; Amanda Mocroft; Fernando Dronda; Niels Obel; Sophie Grabar; Vincenzo Spagnuolo; Eugenia Quiros-Roldan; Cristina Mussini; José M Miro; Laurence Meyer; Barbara Hasse; Deborah Konopnicki; Bernardino Roca; Diana Barger; Gary M Clifford; Silvia Franceschi; Matthias Egger; Julia Bohlius
Journal:  Int J Cancer       Date:  2019-06-19       Impact factor: 7.396

2.  Late presentation of HIV infection in the country of Georgia: 2012-2015.

Authors:  Nikoloz Chkhartishvili; Otar Chokoshvili; Natalia Bolokadze; Maya Tsintsadze; Lali Sharvadze; Pati Gabunia; Natia Dvali; Akaki Abutidze; Tengiz Tsertsvadze
Journal:  PLoS One       Date:  2017-10-30       Impact factor: 3.240

3.  Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation.

Authors:  Klea Panayidou; Mary-Ann Davies; Nanina Anderegg; Matthias Egger
Journal:  J Int AIDS Soc       Date:  2018-11       Impact factor: 5.396

4.  Long-term virological suppression on first-line efavirenz + tenofovir + emtricitabine/lamivudine for HIV-1.

Authors: 
Journal:  AIDS       Date:  2019-03-15       Impact factor: 4.177

5.  Demographic change and HIV epidemic projections to 2050 for adolescents and young people aged 15-24.

Authors:  Aleya Khalifa; John Stover; Mary Mahy; Priscilla Idele; Tyler Porth; Chibwe Lwamba
Journal:  Glob Health Action       Date:  2019       Impact factor: 2.640

6.  All-cause mortality after antiretroviral therapy initiation in HIV-positive women from Europe, Sub-Saharan Africa and the Americas.

Authors: 
Journal:  AIDS       Date:  2020-02-01       Impact factor: 4.632

7.  Clinical features and outcome of patients with primary central nervous system lymphoma admitted to the intensive care unit: a French national expert center experience.

Authors:  Maxens Decavèle; Aliénor Dreyfus; Nicolas Gatulle; Nicolas Weiss; Caroline Houillier; Sophie Demeret; Julien Mayaux; Isabelle Rivals; Martin Dres; Julie Delemazure; Elise Morawiec; Charles-Edouard Luyt; Khe Hoang-Xuan; Sylvain Choquet; Thomas Similowski; Alexandre Demoule
Journal:  J Neurol       Date:  2021-01-16       Impact factor: 4.849

8.  Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs.

Authors: 
Journal:  Clin Infect Dis       Date:  2018-03-05       Impact factor: 9.079

9.  International epidemiology databases to evaluate AIDS (IeDEA) in sub-Saharan Africa, 2012-2019.

Authors:  Frédérique Chammartin; Cam Ha Dao Ostinelli; Kathryn Anastos; Antoine Jaquet; Ellen Brazier; Steven Brown; Francois Dabis; Mary-Ann Davies; Stephany N Duda; Karen Malateste; Denis Nash; Kara Wools-Kaloustian; Per M von Groote; Matthias Egger
Journal:  BMJ Open       Date:  2020-05-15       Impact factor: 2.692

10.  AIDS Therapy Evaluation in the Netherlands (ATHENA) national observational HIV cohort: cohort profile.

Authors:  Tamara Sonia Boender; Colette Smit; Ard van Sighem; Daniela Bezemer; Catriona J Ester; Sima Zaheri; Ferdinand W N M Wit; Peter Reiss
Journal:  BMJ Open       Date:  2018-09-24       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.